Feeble points in the distribution processes of pharmaceutical products provide viable

ground for counterfeit, illegally imported, stolen and substandard medicines to enter the supply

chain. To maintain the original quality of pharmaceutical products, every party involved in the

distribution chain should comply with the applicable practices, legislation and regulations. Each

activity in the distribution of pharmaceutical products should be carried out according to the

principles of Good Manufacturing Practice (GMP), good storage practices (GSP) and good

distribution practices (GDP)